DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents?
Open Access
- 2 February 2009
- journal article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 44 (2), 133-135
- https://doi.org/10.1038/bmt.2008.442
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cellsHaematologica, 2008
- Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusionBone Marrow Transplantation, 2007
- Modulation of brain metabolism by very low concentrations of the commonly used drug delivery vehicle dimethyl sulfoxide (DMSO)Journal of Neuroscience Research, 2007
- Neurotoxicity upon infusion of dimethylsulfoxide‐cryopreserved peripheral blood stem cells in patients with and without pre‐existing cerebral diseaseEuropean Journal of Haematology, 2007
- Bilateral thalamic infarction after reinfusion of DMSO-preserved autologous stem-cellsLeukemia & Lymphoma, 2006
- Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusionLeukemia & Lymphoma, 2005
- Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantationBone Marrow Transplantation, 2003
- Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myelomaBone Marrow Transplantation, 2002
- Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cellsBone Marrow Transplantation, 2000
- Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cellsBone Marrow Transplantation, 2000